SIM
GILD icon

Sprucegrove Investment Management’s Gilead Sciences GILD Stock Holding History

Sprucegrove Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Sell
18,900
-19,000
-50% -$2.5M 0.37% 16
2026
Q1 		$5.28M Sell
37,900
-21,970
-37% -$3.08M 0.85% 8
2025
Q4 		$7.35M Sell
59,870
-107,500
-64% -$13.1M 0.89% 10
2025
Q3 		$18.6M Sell
167,370
-18,200
-10% -$2.07M 1.49% 11
2025
Q2 		$20.6M Sell
185,570
-16,400
-8% -$1.75M 1.66% 10
2025
Q1 		$22.6M Sell
201,970
-66,996
-25% -$6.91M 2.43% 7
2024
Q4 		$24.8M Hold
268,966
– – 1.78% 11
2024
Q3 		$22.6M Sell
268,966
-1,300
-0.5% -$99.2K 1.26% 17
2024
Q2 		$18.5M Buy
270,266
+38,700
+17% +$2.58M 0.96% 21
2024
Q1 		$17M Buy
231,566
+143,600
+163% +$11M 0.69% 26
2023
Q4 		$7.13M Buy
87,966
+1,800
+2% +$140K 0.31% 32
2023
Q3 		$6.46M Sell
86,166
-1,698
-2% -$131K 0.41% 30
2023
Q2 		$6.77M Sell
87,864
-11,736
-12% -$936K 0.35% 31
2023
Q1 		$8.26M Sell
99,600
-1,300
-1% -$108K 0.45% 32
2022
Q4 		$8.66M Sell
100,900
-24,600
-20% -$1.95M 0.48% 32
2022
Q3 		$7.74M Sell
125,500
-12,100
-9% -$763K 0.44% 32
2022
Q2 		$8.51M Sell
137,600
-144,400
-51% -$8.94M 0.42% 33
2022
Q1 		$16.8M Buy
282,000
+34,000
+14% +$2.17M 0.54% 34
2021
Q4 		$18M Sell
248,000
-26,900
-10% -$1.85M 0.45% 35
2021
Q3 		$19.2M Sell
274,900
-2,800
-1% -$197K 0.47% 35
2021
Q2 		$19.1M Sell
277,700
-300
-0.1% -$20K 0.45% 34
2021
Q1 		$18M Sell
278,000
-24,500
-8% -$1.58M 0.44% 35
2020
Q4 		$17.6M Buy
302,500
+162,300
+116% +$9.79M 0.46% 35
2020
Q3 		$8.86M Buy
+140,200
New +$9.72M 0.47% 36

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sprucegrove Investment Management's GILD Position: Q2 2026 in Review

Sprucegrove Investment Management reduced its Gilead Sciences (GILD) stake by 50% in Q2 2026, selling an estimated $2.5M and leaving 18,900 shares worth $2.39M. The position accounts for 0.37% of the portfolio, ranked #16.

Sprucegrove Investment Management first reported a position in GILD in Q3 2020 and has held it in 24 quarters since. The position peaked at $24.8M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sprucegrove Investment Management held 18,900 shares of Gilead Sciences worth $2.39M as of Q2 2026.
  • Sprucegrove Investment Management sold 19,000 Gilead Sciences shares in Q2 2026, an estimated $2.5M.
  • Gilead Sciences made up 0.37% of Sprucegrove Investment Management's portfolio in Q2 2026, its #16 holding.
  • Sprucegrove Investment Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 24 quarters since.
  • Sprucegrove Investment Management's Gilead Sciences position peaked at $24.8M in Q4 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sprucegrove Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.